Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week

  1. Diz-Lois Palomares, M.T.
  2. Sánchez, Á.P.
  3. Pazos, L.E.
  4. Conde, B.G.
  5. Macías, M.O.
  6. Rey, T.V.
  7. Prieto, E.E.
  8. Herranz, I.M.
  9. Aguirre, P.A.
Journal:
Revista Espanola de Enfermedades Digestivas

ISSN: 1130-0108

Year of publication: 2022

Volume: 114

Issue: 12

Pages: 708-712

Type: Article

DOI: 10.17235/REED.2022.8560/2021 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals